Skip to content

Vericel VCEL Change in receivables

Change in receivables at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$14.5M-177%

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's change in receivables?
Vericel (VCEL) reported change in receivables of -$12.25M in Q1 2026.
How has Vericel's change in receivables changed year-over-year?
Vericel's change in receivables decreased by 44.5% year-over-year, from -$8.48M to -$12.25M.
What is the long-term trend for Vericel's change in receivables?
Over 3 years (2021 to 2025), Vericel's change in receivables has grown at a 99.4% compound annual growth rate (CAGR), from $2.93M to $23.26M.
What does change in receivables mean?
Change in total receivables including trade and non-trade receivables.